Upgrade

BriaCell Therapeutics Corp. War

BCTXZ

Last
$0.21
Day
-15.6%
1y
+12.7%
5y
-80.9%
52w
-51.9%
SPY YTD
+13.3%
Sec
—
Earnings
—
EMA 21
0.20
EMA 50
0.17
EMA 200
0.22
20d high
-24.2%
5y high
-83.5%
5y range
13th
Website · Canada

Positions held

Your positions

BCTXZ isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
55
Hold
swing
Signal
Strong Buy
Target
$0.36
Stop
$0.16
Stop distance
24.2%
Target vs last
+70.6%

Fundamentals

Market cap—Enterprise value—Trailing P/E—Forward P/E—
PEG—Price / book0.08Beta1.51Dividend yield—
Revenue growth—Earnings growth—Gross margin0.0%Operating margin0.0%
Profit margin0.0%ROE-1.8%ROA-90.8%Debt / equity—
Current ratio7.07Free cash flow-$20.04MAnalyst recommendationnoneMean target—
52w high$0.2552w low$0.25

Quarterly

2026-Q22026-Q12025-Q42025-Q22025-Q1
Revenue$0.0M$0.0M$0.0M$0.0M$0.0M
Op margin—————
Net income-$7.2M-$7.2M-$8.2M-$6.1M-$6.3M
Gross margin—————
Gross profit—————
Operating income-$7.6M-$7.5M-$8.3M-$6.3M-$7.2M

Yearly (6y)

202420232022
Revenue$0.0M$0.0M$0.0M
Op margin———
Net income-$4.8M-$20.3M-$26.8M
Gross margin———
Gross profit———
Operating income-$33.3M-$23.3M-$15.3M
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

BCTXZ · daily+46.8% over 14 sessions
Close EMA21 EMA50 EMA200
0.130.180.240.290.342026-092026-092026-092026-092026-102026-102026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$8M-$6M-$4M-$2M$0M0%5%10%2025-Q12025-Q22025-Q42026-Q12026-Q2